SinomedTrip
← Back to articles
3 min read
SinomedTrip Team

Wrapping Tumors in Electricity: Tangdu Hospital Uses Irreversible Electroporation to Destroy Cancers Near Critical Structures

Tangdu Hospital deployed irreversible electroporation (NanoKnife) to ablate tumors located near vital blood vessels and bile ducts — destroying cancer cells with electrical pulses while preserving the surrounding structures that other ablation methods would damage.

Medically reviewed by SinomedTrip's clinical team

When Heat Can't Be Used — Electricity Becomes the Weapon

Thermal ablation techniques — radiofrequency ablation (RFA) and microwave ablation (MWA) — have become standard tools for destroying tumors without surgery. But they share a critical limitation: heat damages everything in its path, including blood vessels, bile ducts, and nerves. When a tumor sits adjacent to these critical structures, thermal ablation is either too dangerous or simply impossible.

At Tangdu Hospital (Air Force Medical University, Xi'an), the interventional team has deployed a fundamentally different technology: irreversible electroporation (IRE), commercially known as NanoKnife — a technique that destroys cancer cells with precisely calibrated electrical pulses while leaving the structural scaffolding of blood vessels, bile ducts, and nerves intact.

Tangdu Hospital NanoKnife IRE

How IRE/NanoKnife Works

Unlike heat-based ablation, IRE uses high-voltage, ultra-short electrical pulses (microseconds) delivered through needle electrodes placed around the tumor. These pulses create permanent pores in cancer cell membranes, causing the cells to die through a natural process (apoptosis) rather than thermal destruction.

The critical advantage: connective tissue structures (collagen-based) are resistant to IRE. This means:

StructureThermal AblationIRE/NanoKnife
Blood vesselsDamaged — risk of hemorrhage or thrombosisPreserved
Bile ductsDestroyed — stricture and obstructionPreserved
NervesDamaged — permanent functional lossPreserved (function recovers)
Tumor cellsKilled by heatKilled by membrane disruption

Clinical Applications

IRE is particularly valuable for tumors that are "untouchable" by conventional ablation:

  • Pancreatic tumors — Adjacent to the portal vein, superior mesenteric artery, and bile duct
  • Liver tumors near major vessels — Central hepatic lesions adjacent to the hepatic veins or IVC
  • Bile duct tumors (cholangiocarcinoma) — Where preserving the duct is essential
  • Recurrent tumors after previous ablation — Where thermal injury has already compromised surrounding tissue

The Tangdu team demonstrated successful tumor ablation with post-procedure imaging confirming complete tumor destruction and preserved patency of adjacent critical structures. Tumor markers showed progressive decline on follow-up.

IRE Procedure

Tumor Ablation Cost: China vs Western Countries

ProcedureChina (Tangdu Hospital)United States
IRE/NanoKnife ablation$8,000 - $18,000$30,000 - $80,000
Radiofrequency ablation (RFA)$3,000 - $8,000$15,000 - $40,000
Microwave ablation (MWA)$3,000 - $8,000$15,000 - $40,000
Pancreatic tumor resection (Whipple)$12,000 - $22,000$60,000 - $120,000

China prices include procedure, electrode probes, imaging guidance, hospital stay, and follow-up.

About Tangdu Hospital

  • Affiliated with Air Force Medical University — one of China's top military medical universities
  • Interventional radiology/oncology with NanoKnife and full ablation platform capability
  • Located in Xi'an — SinomedTrip's home city

Frequently Asked Questions

What types of tumors can be treated with NanoKnife (IRE) ablation?

NanoKnife is particularly effective for tumors near critical structures such as major blood vessels, bile ducts, and nerves where heat-based ablation or surgery would cause unacceptable damage. Common applications include pancreatic cancer, liver tumors near major vessels, kidney tumors, and certain prostate cancers. The technology destroys cancer cells using electrical pulses while preserving surrounding connective tissue structures.

Is NanoKnife treatment painful and what is the recovery time?

NanoKnife is performed under general anesthesia, so patients feel no pain during the procedure. Post-procedure discomfort is typically mild and managed with standard pain medication. Most patients are discharged within 2 to 4 days and return to normal activities within 1 to 2 weeks, which is significantly faster than recovery from conventional surgery for the same tumors.

How do I know if NanoKnife is an option for my cancer?

The best way to determine eligibility is to submit your imaging studies (CT and/or MRI) and pathology reports for review by Tangdu Hospital's interventional oncology team. Key factors include tumor size (generally under 5cm), location relative to critical structures, and overall health status. SinomedTrip offers a free initial assessment to help you determine whether NanoKnife is appropriate for your case.

How much does NanoKnife treatment cost in China compared to other countries?

NanoKnife IRE ablation at Tangdu Hospital costs approximately $8,000 to $15,000 depending on the tumor size and location, compared to $30,000 to $60,000 in the United States. This includes the procedure, anesthesia, hospital stay, and post-procedure imaging to assess treatment effectiveness.


Have a tumor near critical structures that's been called "inoperable"? Request a free consultation →

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions.

Related Articles

Light That Kills Cancer: XJTU Hospital Performs First Cholangioscopy-Guided Photodynamic Therapy for Bile Duct Tumors

XJTU First Affiliated Hospital's Lugang campus completed its first photodynamic therapy delivered through a cholangioscope — using targeted light energy to destroy bile duct tumors from the inside without open surgery.

Read More

Not All Cervical Cancers Are Equal: PUMCH Research Shows Why Immunotherapy Works for Some Patients but Not Others

PUMCH's gynecologic oncology team published research revealing that cervical cancer subtypes have fundamentally different immune environments — explaining why PD-1 inhibitors work well for squamous cell carcinoma but fail in adenocarcinoma and neuroendocrine types.

Read More

Breaking Barriers: XJTU Hospital's Multidisciplinary Team Saves Central Asian Patient with Malignant Blood Disease

A patient from Central Asia traveled to XJTU First Affiliated Hospital for treatment of a severe hematological malignancy. The multidisciplinary team delivered successful treatment — demonstrating China's growing role in cross-border medical care.

Read More

No Scars, No Trace: Tongji Hospital Removes Ectopic Parathyroid Tumor Through the Patient's Mouth

A 66-year-old man's parathyroid gland had migrated deep into his chest. Tongji Hospital's thoracic surgery team removed it through an incision inside his lip — leaving zero visible scars on his neck or body.

Read More